258 filings
Page 5 of 13
8-K
zgw2blfzu3k
6 Nov 19
Acceleron Reports Third Quarter 2019 Operating and Financial Results
7:54am
8-K
n1otcgm
16 Sep 19
Acceleron Announces Topline Results from the Phase 2 Trial of ACE-083 in Patients with Facioscapulohumeral Muscular Dystrophy
5:12pm
8-K
a9u5xi8
5 Aug 19
Acceleron Reports Second Quarter 2019 Operating and Financial Results
4:09pm
CT ORDER
bmvq4ltvh5oskhm3dfkf
5 Jul 19
Confidential treatment order
9:51am
8-K
fieqj
10 Jun 19
Departure of Directors or Certain Officers
4:47pm
8-K
2xf6y8uuehs
7 Jun 19
Other Events
4:06pm
8-K
9t7s ityc8b
9 May 19
Acceleron Reports First Quarter 2019 Operating and Financial Results
4:09pm
DEFA14A
ok7ftkfi2zes2
12 Apr 19
Additional proxy soliciting materials
4:22pm
8-K
5ni6f3k
5 Apr 19
Acceleron Discontinues Development of Phase 1 Molecule ACE-2494
5:19pm
S-8
upsi67ycm6d4d1tznfk
27 Feb 19
Registration of securities for employees
4:28pm
8-K
z2a2jam3hvee7o0n
27 Feb 19
Acceleron Reports Fourth Quarter and Full Year 2018 Operating and Financial Results
4:12pm
424B2
b6ndg y7v
17 Jan 19
Prospectus for primary offering
12:00am
8-K
19pcia4whotfawwvd
17 Jan 19
Other Events
12:00am
424B5
3014z89in0u0g0
14 Jan 19
Prospectus supplement for primary offering
5:29pm
8-K
bxeqph
7 Jan 19
Regulation FD Disclosure
7:17am
8-K
eeva65cp7zbzxpxz6fo
3 Dec 18
Regulation FD Disclosure
8:34am